Novartis (NVS) Tops Q4 EPS by 8c; Sees Lower Core Income in FY13
Tweet Send to a Friend
Novartis (NYSE: NVS) reported Q4 EPS of $1.27, $0.08 better than the analyst estimate of $1.19. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
